Regeneron Pharmaceuticals REGN Preferred Stock, Par or Stated Value Per Share
Preferred Stock, Par or Stated Value Per Share at other companies
Other financials
Where this comes from
Reported directly by Regeneron Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockParOrStatedValuePerShare.
The official record: Regeneron Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Regeneron Pharmaceuticals's preferred stock, par or stated value per share.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Regeneron Pharmaceuticals's preferred stock, par or stated value per share?
- Regeneron Pharmaceuticals (REGN) reported preferred stock, par or stated value per share of $0.01 in Q1 2026.
- How has Regeneron Pharmaceuticals's preferred stock, par or stated value per share changed year-over-year?
- Regeneron Pharmaceuticals's preferred stock, par or stated value per share decreased by 0.0% year-over-year, from $0.01 to $0.01.
- What is the long-term trend for Regeneron Pharmaceuticals's preferred stock, par or stated value per share?
- Over 5 years (2020 to 2025), Regeneron Pharmaceuticals's preferred stock, par or stated value per share has grown at a 0.0% compound annual growth rate (CAGR), from $0.01 to $0.01.